1
|
Choi B, Jang JH, Son M, Lee MS, Jo YY, Jeon JY, Jin U, Soh M, Park RW, Kwon JM. Electrocardiographic biomarker based on machine learning for detecting overt hyperthyroidism. EUROPEAN HEART JOURNAL. DIGITAL HEALTH 2022; 3:255-264. [PMID: 36713007 PMCID: PMC9707932 DOI: 10.1093/ehjdh/ztac013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Revised: 03/16/2022] [Accepted: 03/28/2022] [Indexed: 02/01/2023]
Abstract
Aims Although overt hyperthyroidism adversely affects a patient's prognosis, thyroid function tests (TFTs) are not routinely conducted. Furthermore, vague symptoms of hyperthyroidism often lead to hyperthyroidism being overlooked. An electrocardiogram (ECG) is a commonly used screening test, and the association between thyroid function and ECG is well known. However, it is difficult for clinicians to detect hyperthyroidism through subtle ECG changes. For early detection of hyperthyroidism, we aimed to develop and validate an electrocardiographic biomarker based on a deep learning model (DLM) for detecting hyperthyroidism. Methods and results This multicentre retrospective cohort study included patients who underwent ECG and TFTs within 24 h. For model development and internal validation, we obtained 174 331 ECGs from 113 194 patients. We extracted 48 648 ECGs from 33 478 patients from another hospital for external validation. Using 500 Hz raw ECG, we developed a DLM with 12-lead, 6-lead (limb leads, precordial leads), and single-lead (lead I) ECGs to detect overt hyperthyroidism. We calculated the model's performance on the internal and external validation sets using the area under the receiver operating characteristic curve (AUC). The AUC of the DLM using a 12-lead ECG was 0.926 (0.913-0.94) for internal validation and 0.883(0.855-0.911) for external validation. The AUC of DLMs using six and a single-lead were in the range of 0.889-0.906 for internal validation and 0.847-0.882 for external validation. Conclusion We developed a DLM using ECG for non-invasive screening of overt hyperthyroidism. We expect this model to contribute to the early diagnosis of diseases and improve patient prognosis.
Collapse
Affiliation(s)
| | | | - Minkook Son
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea
| | - Min Sung Lee
- Department of Medical Research, Medical AI Co., Seoul, Republic of Korea
| | - Yong Yeon Jo
- Department of Medical Research, Medical AI Co., Seoul, Republic of Korea
| | - Ja Young Jeon
- Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea
| | - Uram Jin
- Department of Cardiology, Ajou University School of Medicine, Suwon, Republic of Korea
| | - Moonseung Soh
- Department of Cardiology, Ajou University School of Medicine, Suwon, Republic of Korea
| | | | | |
Collapse
|
2
|
Fornaro M, Stubbs B, De Berardis D, Iasevoli F, Solmi M, Veronese N, Carano A, Perna G, De Bartolomeis A. Does the " Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients. Clin Pract Epidemiol Ment Health 2016; 12:142-157. [PMID: 28217142 PMCID: PMC5278557 DOI: 10.2174/1745017901612010142] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2016] [Revised: 10/03/2016] [Accepted: 10/08/2016] [Indexed: 01/14/2023]
Abstract
Background: Though often perceived as a “silver bullet” treatment for bipolar disorder (BD), lithium has seldom reported to lose its efficacy over the time. Objective: The aim of the present study was to assess cases of refractoriness toward restarted lithium in BD patients who failed to preserve maintenance. Method: Treatment trajectories associated with re-instituted lithium following loss of achieved lithium-based maintenance in BD were retrospectively reviewed for 37 BD-I patients (median age 52 years; F:M=17:20 or 46% of the total) over an 8.1-month period on average. Results: In our sample only 4 cases (roughly 11% of the total, of whom F:M=2:2) developed refractoriness towards lithium after its discontinuation. Thirty-three controls (F:M=15:18) maintained lithium response at the time of re-institution. No statistically significant difference between cases and controls was observed with respect to a number of demographic and clinical features but for time spent before first trial ever with lithium in life (8.5 vs. 3 years; U=24.5, Z=-2.048, p=.041) and length of lithium discontinuation until new therapeutic attempt (5.5 vs. 2 years; U=8, Z=-2.927, p=.003) between cases vs. controls respectively. Tapering off of lithium was significantly faster among cases vs. controls (1 vs. 7 days; U=22, Z=-2.187), though both subgroups had worrisome high rates of poor adherence overall. Conclusion: Although intrinsic limitations of the present preliminary assessment hamper the validity and generalizability of overall results, stating the clinical relevance of the topic further prospective research is warranted. The eventual occurrence of lithium refractoriness may indeed be associated with peculiar course trajectories and therapeutic outcomes ultimately urging the prescribing clinicians to put efforts in preserving maintenance of BD in the absence of any conclusive research insight on the matter.
Collapse
Affiliation(s)
- M Fornaro
- New York State Psychiatric Institute (NYPSI); Columbia University, NYC, NY, USA
| | - B Stubbs
- Physiotherapy Department, South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK; Health Service and Population Research Department, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK
| | - D De Berardis
- National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, "G. Mazzini" Hospital, ASL 4 Teramo, Italy
| | - F Iasevoli
- Outpatient Unit on Treatment Resistant Psychosis, Department of Neuroscience, University School of Medicine Federico II, Naples, Italy
| | - M Solmi
- Department of Neurosciences, University of Padova, Padova, Italy; I.R.E.M. (Institute for clinical Research and Education in Medicine), Padova, Italy
| | - N Veronese
- I.R.E.M. (Institute for clinical Research and Education in Medicine), Padova, Italy; Geriatrics Section, Department of Medicine (DIMED), University of Padova, Padova, Italy
| | - A Carano
- Hospital "C. G. Mazzoni", Ascoli Piceno, Italy
| | - G Perna
- Department of Clinical Neurosciences, Hermanas Hospitalarias, FoRiPsi, Villa San Benedetto Menni, Albese con Cassano, 22032 Como, Italy; Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, Netherlands; Department of Psychiatry and Behavioral Sciences, Leonard Miller School of Medicine, Miami University, Miami, FL 33136, USA
| | - A De Bartolomeis
- Outpatient Unit on Treatment Resistant Psychosis, Department of Neuroscience, University School of Medicine Federico II, Naples, Italy
| |
Collapse
|
3
|
Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Relational Stability in the Expression of Normality, Variation, and Control of Thyroid Function. Front Endocrinol (Lausanne) 2016; 7:142. [PMID: 27872610 PMCID: PMC5098235 DOI: 10.3389/fendo.2016.00142] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2016] [Accepted: 10/21/2016] [Indexed: 12/31/2022] Open
Abstract
Thyroid hormone concentrations only become sufficient to maintain a euthyroid state through appropriate stimulation by pituitary thyroid-stimulating hormone (TSH). In such a dynamic system under constant high pressure, guarding against overstimulation becomes vital. Therefore, several defensive mechanisms protect against accidental overstimulation, such as plasma protein binding, conversion of T4 into the more active T3, active transmembrane transport, counter-regulatory activities of reverse T3 and thyronamines, and negative hypothalamic-pituitary-thyroid feedback control of TSH. TSH has gained a dominant but misguided role in interpreting thyroid function testing in assuming that its exceptional sensitivity thereby translates into superior diagnostic performance. However, TSH-dependent thyroid disease classification is heavily influenced by statistical analytic techniques such as uni- or multivariate-defined normality. This demands a separation of its conjoint roles as a sensitive screening test and accurate diagnostic tool. Homeostatic equilibria (set points) in healthy subjects are less variable and do not follow a pattern of random variation, rather indicating signs of early and progressive homeostatic control across the euthyroid range. In the event of imminent thyroid failure with a reduced FT4 output per unit TSH, conversion efficiency increases in order to maintain FT3 stability. In such situations, T3 stability takes priority over set point maintenance. This suggests a concept of relational stability. These findings have important implications for both TSH reference limits and treatment targets for patients on levothyroxine. The use of archival markers is proposed to facilitate the homeostatic interpretation of all parameters.
Collapse
Affiliation(s)
- Rudolf Hoermann
- Department of Nuclear Medicine, Klinikum Luedenscheid, Luedenscheid, Germany
| | | | - Rolf Larisch
- Department of Nuclear Medicine, Klinikum Luedenscheid, Luedenscheid, Germany
| | - Johannes W. Dietrich
- Medical Department I, Endocrinology and Diabetology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany
- Ruhr Center for Rare Diseases (CeSER), Ruhr University of Bochum, Bochum, Germany
- Ruhr Center for Rare Diseases (CeSER), Witten/Herdecke University, Bochum, Germany
| |
Collapse
|
4
|
Leese GP, Jung RT, Browning MC. Feasibility of reducing L-thyroxine dose in patients with a suppressed serum TSH. Scott Med J 1995; 40:171-3. [PMID: 8693333 DOI: 10.1177/003693309504000605] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
A total of 748 patients on L-thyroxine with a suppressed serum TSH were requested to reduce their dose and this was achieved in 601 patients. Thyroxine dosage was reduced by 25 or 50 micrograms of L-thyroxine and patients were reviewed six months later. Of all 601 patients, 54.4% remained with a suppressed serum TSH despite dose reduction and in 5.8% an elevated serum TSH resulted. 25 micrograms reductions and 50 micrograms reductions were equally likely to result in an detectable but non-elevated serum TSH (42.8% vs 34.1% ns) but 25 micrograms reductions were less likely to result in an elevated serum TSH (3.8% vs 10.0% p < 0.01). Only 7/601 patients in the study (1.2%) appeared to require a dose of over 150 micrograms. If dose reduction is thought to be necessary for patients with a suppressed serum TSH, we would recommend 50 micrograms reductions if the original dose is 200 micrograms or more, and 25 micrograms reductions if the original dose is 175 micrograms or less.
Collapse
Affiliation(s)
- G P Leese
- Department of Medicine, Ninewells Hospital, Dundee
| | | | | |
Collapse
|
5
|
Squire CR, Fraser WD. Thyroid stimulating hormone measurement using a third generation immunometric assay. Ann Clin Biochem 1995; 32 ( Pt 3):307-13. [PMID: 7632036 DOI: 10.1177/000456329503200308] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
After an initial evaluation of the standard procedure for performance of a third generation TSH (thyroid stimulating hormone) assay (Amerlite TSH-30) modifications were made to standardize the timing of measurement of light emission following signal reagent addition. By adopting this optimized procedure, a significant improvement in assay sensitivity was achieved when compared to a second generation TSH assay (DAKO). Using the optimized assay the sensitivity was 0.003 mU/L (20 replicates of zero) or 0.009 mU/L [22% CV (coefficient of variation) from the precision profile]. Recovery of added TSH and parallelism of the assay were good. A significant negative bias was detected for the Amerlite TSH-30 assay when compared to the DAKO assay (log y = 0.92 log x-0.33, n = 210). Excellent discrimination was achieved between euthyroid, hypothyroid and thyrotoxic subjects. A high percentage of thyrotoxic patients had undetectable TSH and the spread of values between thyrotoxic and euthyroid was greater with the third generation assay. In patients receiving thyroxine therapy a higher percentage had detectable TSH values. The optimized Amerlite TSH 30 assay offers improved assay performance when compared to a second generation assay.
Collapse
Affiliation(s)
- C R Squire
- University Department of Clinical Chemistry, Royal Liverpool University Hospital, UK
| | | |
Collapse
|
6
|
De Whalley P. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract 1995; 45:93-5. [PMID: 7702890 PMCID: PMC1239143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
BACKGROUND Hypothyroidism is a common disorder, easily treated with thyroxine therapy. Thyroid stimulating hormone level assay can detect under- or overtreatment. AIM A study was carried out in one general practice to discover the number of people on thyroxine therapy, their care, and whether abnormal thyroid stimulating hormone level values resulted in alterations to their thyroxine dose. METHOD The study was undertaken in a north Suffolk general practice of 7640 patients. A computer search identified patients receiving repeat prescriptions for thyroxine therapy and their notes were studied. A thyroid stimulating hormone level value in the range of 0.3-3.8 mU l-1 was considered to indicate an appropriate thyroxine dose. RESULTS Thyroxine was being taken by 162 patients (2%), of whom 146 were women. Thyroid stimulating hormone level had been checked within the last year for 127 patients (78%). At their last thyroid stimulating hormone level test, 48 patients (30%) had a value above the normal range, only 21 of whom (44%) had their thyroxine dose increased as a result. The thyroid stimulating hormone level was below 0.3 mU l-1 at the last check in 38 patients (23%), only four of whom (11%) had their thyroxine dose reduced as a result. CONCLUSION There is often failure to adjust thyroxine dose despite abnormal thyroid stimulating hormone levels. However, more research is needed to determine the ideal thyroid stimulating hormone levels which should be aimed for in these patients, and whether tight control of thyroxine dosage is able to reduce morbidity and mortality among patients with hypothyroidism.
Collapse
|
7
|
Johnston J, McLelland A, O'Reilly DS. The relationship between serum cholesterol and serum thyroid hormones in male patients with suspected hypothyroidism. Ann Clin Biochem 1993; 30 ( Pt 3):256-9. [PMID: 8517607 DOI: 10.1177/000456329303000305] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The relationship between serum cholesterol, thyrotropin, thyroxine and triiodothyronine was investigated in 456 male patients with suspected hypothyroidism. The correlation between serum cholesterol and serum thyroxine (r = 0.0572) and between serum cholesterol and serum triiodothyronine (r = 0.1136) were not significant but the correlation between serum cholesterol and TSH (r = 0.0376) was significant (P < 0.001). The mean serum cholesterol was only significantly increased in the patient groups with a serum TSH greater than 20 mU/L. In 26 patients treated for hypothyroidism with thyroxine replacement there was a significant correlation between the decrease in serum cholesterol and the decrease in serum TSH (r = 0.5334, P < 0.01) but there was poor correlation between the decrease in cholesterol and either the increase in serum triiodothyronine or the increase in serum thyroxine.
Collapse
Affiliation(s)
- J Johnston
- Institute of Biochemistry, Royal Infirmary, Glasgow, Scotland, UK
| | | | | |
Collapse
|
8
|
Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993; 43:107-9. [PMID: 8323787 PMCID: PMC1372330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Examination of thyroxine usage in a study in the United States of America revealed that many patients were prescribed thyroxine for non-thyroid indications, such as obesity and fatigue. Many of those receiving thyroxine had high or low serum thyroid stimulating hormone levels, indicating prescription of incorrect doses or lack of patient compliance with therapy. Long term thyroxine therapy may have effects upon the risk of osteoporosis. The aims of this study were to investigate indications for thyroxine prescription in the United Kingdom and to examine the frequency of abnormal serum thyroid stimulating hormone concentrations in those prescribed thyroxine for hypothyroidism. This was in order to determine the relevance of measurement of thyroid stimulating hormone level in monitoring thyroxine therapy. Subjects receiving thyroxine were identified from the computerized prescribing records of four general practices in the West Midlands. Of 18,944 patients registered, 146 (0.8%) were being prescribed thyroxine; 134 of these had primary hypothyroidism and the remainder had other thyroid or pituitary diseases prior to treatment. Of the 97 patients with primary hypothyroidism who agreed to have their thyroid stimulating hormone level measured, abnormal serum levels were found in 48%, high levels in 27% and low levels in 21%. There was a significant relationship between prescribed thyroxine dose and median serum thyroid stimulating hormone level: high hormone levels were found in 47% of those prescribed less than 100 micrograms thyroxine per day, while low levels were found in 24% of those prescribed 100 micrograms or more. Thus, thyroxine prescription was common in the four practices sampled, although indications for its use were appropriate.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- J V Parle
- Department of Medicine, University of Birmingham
| | | | | | | | | |
Collapse
|
9
|
Nuutila P, Irjala K, Saraste M, Seppälä P, Viikari J. Cardiac systolic time intervals and thyroid hormone levels during treatment of hypothyroidism. Scand J Clin Lab Invest 1992; 52:467-77. [PMID: 1411259 DOI: 10.3109/00365519209090123] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
This study was undertaken to compare results of modern serum thyroid hormone assays with cardiac systolic time intervals (STI) during thyroxine treatment in hypothyroid patients. The patients were assessed clinically (Billewicz index) and the STI and serum thyrotropin (TSH), total and free thyroxine (T4) and total and free triiodothyronine (T3) were determined in 16 hypothyroid women (Group I) treated with 50 micrograms increments of thyroxine, and in 13 women who had a history of thyroid carcinoma and high-dose thyroxine replacement therapy and had elevated thyroid hormone concentrations (Group II). The STI of 24 matched healthy female controls were used for reference of STI. The pre-ejection period (PEP) index and the PEP/LVET ratio (left ventricular ejection period) were greater in untreated overtly and mildly hypothyroid patients (p less than 0.05) than in the controls. During stable thyroxine therapy [mean daily dosage for Group I 137.5 (7.3) micrograms and for Group II 220 (61) micrograms] the PEP correlated with serum free T4 (FT4), as measured by a two-step method (SpectriaR) (r = -0.55, p less than 0.01, n = 29) and total T4 (r = -0.51, p less than 0.05, n = 29), but not with TSH, T3, FT3 or FT4 measured by an analogue method Amerlex-M(R). The TRH test was not valuable in follow-up because of the strong correlation between basal TSH and stimulated TSH values (r = 0.95). In conclusion, STI are useful for assessment of the thyroid state in untreated hypothyroid patients. Serum TSH becomes normal in the same time as STI and is the best for follow-up. If serum TSH is low and the patient is on stable thyroxine therapy, we recommend serum FT4 for monitoring thyroxine replacement. Two-step FT4 assays had the best correlation with STI, which has significance in patients with non-thyroidal illness.
Collapse
Affiliation(s)
- P Nuutila
- Department of Medicine, University Central Hospital of Turku, Finland
| | | | | | | | | |
Collapse
|
10
|
Rapp MS, Bibr J, Campbell K. The use of laboratory tests in a psychiatric hospital. CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE 1992; 37:137-9. [PMID: 1562959 DOI: 10.1177/070674379203700213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Little attention has been paid to the use of laboratory tests in psychiatric hospitals. This paper reviews studies of the use and abuse of laboratory tests in general medicine. It examines five different sets of test results performed over a three month period at a mid-sized psychiatric hospital. The paper concludes that, on the whole, the laboratory was used efficiently and effectively. However, some testing patterns need to be re-evaluated.
Collapse
Affiliation(s)
- M S Rapp
- Whitby Psychiatric Hospital, Ontario
| | | | | |
Collapse
|
11
|
Jadoul M, Ferrant A, De Plaen JF, Crabbé J. Mineralocorticoids in the management of primary adrenocortical insufficiency. J Endocrinol Invest 1991; 14:87-91. [PMID: 2061574 DOI: 10.1007/bf03350272] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Plasma renin activity (PRA) and plasma volume (PV) were determined in 22 adult patients treated for Addison's disease (AD) and reporting at the clinic for follow-up. Mean PRA was thrice the upper limit of normal (9.1 +/- 7.1 ng/ml/h (SD)) and mean PV was decreased (87% +/- 11 (SD)), consistent with residual hypovolemia in most patients, despite conventional treatment with both fluorocortisol (FF) and cortisone acetate. There was an inverse relationship between PRA and PV. Both PRA and PV were significantly correlated with FF dosage. On the other hand, no correlation was found between PV and either systolic or diastolic blood pressure (BP), while PRA was significantly correlated with systolic but not diastolic BP. Four patients were persistently hypertensive (diastolic BP greater than 100 mmHg) with elevated PRA in 3, associated with a definitely low PV in two cases. Two of these patients were progressively taken off FF, so as to control BP. Thus, in view of the not infrequent occurrence of arterial hypertension in AD patient on conventional treatment, we would warn against attempts at normalizing PV and PRA by means of FF, irrespective of BP in asymptomatic cases. In fact, when hypertension develops, reduction or sometimes withdrawal of FF may be recommended as a first therapeutic step.
Collapse
Affiliation(s)
- M Jadoul
- Department of Nephrology, University Clinics St-Luc, University of Louvain Medical School, Brussels, Belgium
| | | | | | | |
Collapse
|
12
|
Affiliation(s)
- A D Toft
- University Department of Medicine, Royal Infirmary, Edinburgh, UK
| |
Collapse
|
13
|
Thomas SH, Sturgess I, Wedderburn A, Wylie J, Croft DN. Clinical versus biochemical assessment in thyroxine replacement therapy: a retrospective study. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON 1990; 24:289-91. [PMID: 2258844 PMCID: PMC5387522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
A retrospective audit of a thyroid clinic revealed that only 67% of clinical assessments of thyroid status in patients receiving thyroxine replacement therapy were correct. The identification of patients on excessive doses of thyroxine appears to be the most difficult by clinical assessment alone, only 10% of those patients with a suppressed TSH level being identified. This study emphasises the importance of thyroid function tests in the assessment of patients on thyroxine replacement.
Collapse
Affiliation(s)
- S H Thomas
- Department of Clinical Pharmacology, St Thomas's Hospital, London
| | | | | | | | | |
Collapse
|
14
|
Elder J, McLelland A, O'Reilly DS, Packard CJ, Series JJ, Shepherd J. The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem 1990; 27 ( Pt 2):110-3. [PMID: 2327707 DOI: 10.1177/000456329002700204] [Citation(s) in RCA: 58] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The relationship between serum cholesterol, thyrotropin, thyroxine and tri-iodothyronine was investigated in 1018 female patients over 40 years of age with suspected hypothyroidism. The correlation between serum thyrotropin and cholesterol (r = 0.398) and between thyroxine and cholesterol (r = -0.217) were both highly significant (P less than 0.001), but the correlation between tri-iodothyronine and cholesterol (r = -0.011) was not significant. Only in patients with a serum thyrotropin in excess of 40 mU/L was there a clinically appreciable increase in the serum cholesterol. In 139 patients treated for hypothyroidism by thyroxine replacement there was a highly significant correlation (P less than 0.001) between the decrease in serum thyrotropin and cholesterol (r = 0.593). The correlation between increase in serum thyroxine and decrease in cholesterol (r = -0.401) was also highly significant (P less than 0.001), but there was an even stronger correlation between the increase in serum tri-iodothyronine and the decrease in serum cholesterol (r = -0.529).
Collapse
Affiliation(s)
- J Elder
- Institute of Biochemistry, Royal Infirmary, Glasgow, Scotland
| | | | | | | | | | | |
Collapse
|
15
|
Wellby ML. Clinical chemistry of thyroid function testing. Adv Clin Chem 1990; 28:1-92. [PMID: 2077874 DOI: 10.1016/s0065-2423(08)60134-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M L Wellby
- Department of Clinical Chemistry, Queen Elizabeth Hospital, Woodville, Adelaide, South Australia
| |
Collapse
|
16
|
Nyström E, Lundberg PA, Petersen K, Bengtsson C, Lindstedt G. Evidence for a slow tissue adaptation to circulating thyroxine in patients with chronic L-thyroxine treatment. Clin Endocrinol (Oxf) 1989; 31:143-50. [PMID: 2605792 DOI: 10.1111/j.1365-2265.1989.tb01237.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
We measured serum procollagen-III-peptide in 67 women with long-term L-thyroxine treatment and compared the results with age-matched controls. The strong correlation between serum free thyroxine and procollagen-III-peptide concentrations previously found after 6 months of L-thyroxine treatment was not found after long-term treatment. There were slightly higher procollagen-III-peptide concentration values in those chronically treated patients who had high free thyroxine levels but this increase was less marked than in patients previously studied after short-term treatment. An increase in procollagen-III-peptide concentration reflects an increased biosynthesis of collagen III, which is present in connective tissues throughout the body, and our findings may be explained by slow tissue adaptation to increased levels of thyroxine. We conclude that the increased thyroxine levels found in L-thyroxine-treated patients are of less clinical importance than thought previously. We also conclude that peripheral markers of thyroid hormone peripheral effects such as procollagen-III-peptide may be of less use than thought previously due to this slow tissue adaptation to changes in thyroxine concentration.
Collapse
Affiliation(s)
- E Nyström
- Department of Medicine 2, Sahlgren's Hospital, Gothenburg, Sweden
| | | | | | | | | |
Collapse
|
17
|
|
18
|
Abstract
Many patients taking customary doses of levothyroxine have slightly elevated serum thyroxine (T4), apparently normal serum triiodothyronine, suppressed serum thyrotropin (thyroid-stimulating hormone; TSH) concentrations, and no clinical symptoms of hyperthyroidism. Recent reports suggest that these patients may have adverse effects from subclinical hyperthyroidism, including abnormally short systolic time intervals, elevations in liver enzymes, and reductions in bone density. Controversy exists about which thyroid function tests should be used to monitor patients taking levothyroxine. A review of currently available data suggests that replacement doses of levothyroxine given to hypothyroid patients should be adjusted so that serum TSH measured by the new sensitive assays is within the normal range. Patients requiring suppressive doses of levothyroxine to shrink goitrous thyroid tissue or to prevent growth of abnormal tissue should be given the minimal dose needed to accomplish the desired clinical or biochemical response.
Collapse
Affiliation(s)
- D S Ross
- Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston
| |
Collapse
|
19
|
Jaeschke R. Thyroxine replacement therapy. Clin Endocrinol (Oxf) 1988; 29:689-90. [PMID: 3151479 DOI: 10.1111/j.1365-2265.1988.tb03717.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
20
|
Stockigt JR. The laboratory evaluation of abnormal endocrine function: the fallacy of seeking a single test. Med J Aust 1988; 149:171-3. [PMID: 3050391 DOI: 10.5694/j.1326-5377.1988.tb120564.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
21
|
Leslie PJ, Toft AD. The replacement therapy problem in hypothyroidism. BAILLIERE'S CLINICAL ENDOCRINOLOGY AND METABOLISM 1988; 2:653-69. [PMID: 3066323 DOI: 10.1016/s0950-351x(88)80058-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
There is increasing evidence from studies of heart rate, liver enzyme activity, bone density and urinary sodium excretion that standard replacement therapy doses of thyroxine which suppress TSH secretion are associated with changes in target organ function similar to, but less marked than, those recorded in overt hyperthyroidism. There is also evidence that in subclinical hypothyroidism it is not only the pituitary thyrotroph which recognizes a minor reduction in serum thyroid hormone levels within the normal range. Although there is no proof that slight 'overtreatment' with thyroxine or non-treatment of subclinical hypothyroidism is detrimental to the patient in the long term, the appropriate studies have not been performed. It would seem good clinical practice, however, to treat all grades of thyroid failure and to ensure, if possible, that the dose of thyroxine is adjusted to maintain a normal and detectable TSH level when measured by a sensitive assay system. It must be conceded, however, that with the vagaries of human nature there is always likely to be greater morbidity from patients with hypothyroidism failing to take their medication regularly, than from failure by the medical attendant to make minor adjustments to the dose of thyroxine.
Collapse
|
22
|
Lipworth BJ, Dhillon DP, Clark RA, Newton RW. Problems with asthma following treatment of thyrotoxicosis. BRITISH JOURNAL OF DISEASES OF THE CHEST 1988; 82:310-4. [PMID: 3248214 DOI: 10.1016/0007-0971(88)90075-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
We describe two cases of asthma associated with concomitant thyrotoxicosis where initial improvement followed antithyroid treatment. Relapse of asthma on thyroxine replacement was accompanied by subclinical hyperthyroidism with elevated levels of triiodothyronine. This emphasizes the need to follow up asthmatic patients closely for biochemical relapse following treatment of thyrotoxicosis.
Collapse
Affiliation(s)
- B J Lipworth
- Department of Thoracic Medicine, King's Cross Hospital, Dundee
| | | | | | | |
Collapse
|
23
|
Letters to the Editor. Med Chir Trans 1988. [DOI: 10.1177/014107688808100629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
24
|
Rippere V. Euthyroid hyperthyroxinaemia. J R Soc Med 1988; 81:369. [PMID: 3404534 PMCID: PMC1291645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
|
25
|
Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 1988; 28:325-33. [PMID: 3139338 DOI: 10.1111/j.1365-2265.1988.tb01219.x] [Citation(s) in RCA: 136] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Thyroxine replacement therapy for 21 adult patients with primary hypothyroidism was adjusted to the dosage at which each patient had a normal thyrotrophin (TSH) response to thyrotrophin releasing hormone (TRH). Clinical assessment and measurement of TSH (by sensitive immunoradiometric assay), free thyroxine (FT4) and free tri-iodothyronine (FT3) were made at this dosage and at higher and lower doses of thyroxine. Clinical observations, FT3 and FT4 assays were relatively insensitive to small alterations of thyroxine dosage, in contrast to which basal TSH measurements correlated well with TRH responsiveness and were sensitive to fine adjustments of thyroxine dosage.
Collapse
Affiliation(s)
- D Carr
- Department of Medicine, North Tees General Hospital, Stockton-on-Tees, Cleveland, UK
| | | | | | | |
Collapse
|
26
|
Wood WG, Rohde C, Jacobs A. A comparison of commercially available luminescence enhanced enzyme immunoassays with in-house non-radioisotopic assays for thyroxine binding globulin and total thyroxine. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY. ZEITSCHRIFT FUR KLINISCHE CHEMIE UND KLINISCHE BIOCHEMIE 1988; 26:135-40. [PMID: 3133446 DOI: 10.1515/cclm.1988.26.3.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Commercial luminescence enhanced enzyme immunoassays (Amersham-Amerlite) for thyroxine binding globulin (TBG) and total thyroxine (TT4) were compared with the in-house methods (TT4--Abbott TDx, TBG--Immunoluminometric Assay (ILMA)). The experimental groups consisted of 108 healthy euthyroid blood donors, 165 non-selected thyroid outpatients, 44 tumour bearers and 84 haemodialysis patients. Total thyroxine/thyroxine binding globulin quotients were constructed as an index of thyroid function. The luminescence enhanced enzyme immunoassays were precise (interassay coefficients of variation less than 10% in the range 5-45 mg/l thyroxine binding globulin and 20-100 micrograms/l for total thyroxine) performed similarly to the in-house methods in the differentiation of eu-, hypo- and hyperthyroidism on the basis of total thyroxine/thyroxine binding globulin quotients. Although statistically significant differences often occurred in comparisons of the in-house method with the luminescence enhanced enzyme immunoassays, these only gave rise to thyroid status differences in two cases out of 273, where the in-house method gave a hyperthyroid, the luminescence enhanced enzyme immunoassay a euthyroid answer, when taken from the total thyroxine/thyroxine binding globulin quotients. The luminescence enhanced enzyme immunoassays performed as well as the in-house methods, and quality assessment data were comparable with their radioimmunological counterparts.
Collapse
Affiliation(s)
- W G Wood
- Klinische Laboratorien, Medizinische Universität zu Lübeck
| | | | | |
Collapse
|
27
|
White AJ, Barraclough B. Thyroid disease and mental illness: a study of thyroid disease in psychiatric admissions. J Psychosom Res 1988; 32:99-106. [PMID: 3404495 DOI: 10.1016/0022-3999(88)90093-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
The notes of 1007 consecutive admissions to a District General Hospital adult psychiatry unit were examined retrospectively to establish the role of the thyroid disease detected in routine management. Thyroid function tests were performed on 300 admissions, leaving 707 untested. Ten had abnormal results (3.3% of admissions tested), accounted for by nine patients with affective disorder. Two of the nine settled spontaneously, but seven cases (2.3%) had sustained abnormality. Five of the seven had a known history of thyroid disease, leaving two new findings of hypothyroidism who presented with no clinical signs other than their mental illness (0.7% of admissions tested). In five cases, which included the two new findings, the thyroid disease had been judged to precipitate the mental illness. All cases except one transitory abnormality occurred in females. When the results of this and other surveys are compared with the figures for thyroid disease in the general population, the value of screening psychiatric patients seems questionable. However, diagnosis is important in a few cases where thyroid disease apparently contributes to the mental illness. For psychiatric patients aged up to 65, elimination of unnecessary thyroid function tests without sacrificing detection may be possible by restricting use to female patients with affective disorder, patients with a past or family history of thyroid disease or with presenile dementia. Abnormal results obtained during the acute phase of the illness may be transitory and require confirmation.
Collapse
Affiliation(s)
- A J White
- University Department of Psychiatry, Royal South Hants Hospital, Southampton, U.K
| | | |
Collapse
|
28
|
Wheatley T, Clark PM, Clark JD, Raggatt PR, Edwards OM. Thyroid stimulating hormone measurement by an ultrasensitive assay during thyroxine replacement: comparison with other tests of thyroid function. Ann Clin Biochem 1987; 24 ( Pt 6):614-9. [PMID: 3122632 DOI: 10.1177/000456328702400611] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Serum thyroid stimulating hormone (TSH) was measured using a highly sensitive enzyme-amplified immunoassay in 37 clinically euthyroid patients receiving thyroxine replacement therapy and compared with other biochemical tests of thyroid function. A highly significant correlation (P less than 0.001) was found between the basal serum TSH and the increase in serum TSH concentration 20 min after the administration of thyrotropin releasing hormone (TRH). The basal serum TSH was negatively correlated with the serum total thyroxine (P = 0.05). When patients results were classified as abnormal or normal many discrepancies were noted between the various thyroid tests. A suppressed serum TSH was found in 65% of patients with a normal serum total thyroxine. However, in patients on thyroxine replacement therapy a basal TSH measured by enzyme-amplified immunoassay provides the same information as a TRH test.
Collapse
Affiliation(s)
- T Wheatley
- Department of Diabetes and Endocrinology, Addenbrooke's Hospital, Cambridge, UK
| | | | | | | | | |
Collapse
|
29
|
Squire CR, Gimlette TM. Assessment of an enhanced chemiluminescent immunometric assay for TSH in 1127 patients. Ann Clin Biochem 1987; 24 ( Pt 4):419-25. [PMID: 3662391 DOI: 10.1177/000456328702400412] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
An enhanced immunochemiluminometric assay for serum TSH ('Amerlite', Amersham, Bucks, UK) was studied in 1127 patients in routine clinical practice to assess its value as a first-line test of thyroid status. Good correlation with clinical thyroid status was found in the untreated euthyroid patients, in the untreated hyperthyroid and hypothyroid patients, in pregnancy and in the sick euthyroid. However, a large proportion of clinically euthyroid patients with nodular goitre, as well as those treated by thyroidectomy, radioiodine or antithyroid drugs and those on replacement l-thyroxine showed TSH values outside the reference range. Therefore, additional tests are likely to be needed frequently in these categories.
Collapse
Affiliation(s)
- C R Squire
- Department of Nuclear Medicine, Royal Liverpool Hospital, UK
| | | |
Collapse
|